These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25318752)

  • 1. Intravenous iron exposure and outcomes in patients on hemodialysis.
    Fishbane S; Mathew AT; Wanchoo R
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1837-9. PubMed ID: 25318752
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous iron exposure and mortality in patients on hemodialysis.
    Miskulin DC; Tangri N; Bandeen-Roche K; Zhou J; McDermott A; Meyer KB; Ephraim PL; Michels WM; Jaar BG; Crews DC; Scialla JJ; Sozio SM; Shafi T; Wu AW; Cook C; Boulware LE;
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1930-9. PubMed ID: 25318751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia management and mortality risk in incident hemodialysis patients.
    Auerbach M
    JAMA; 2010 Jul; 304(1):41-2; author reply 42-3. PubMed ID: 20606145
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous iron dose and mortality in hemodialysis patients.
    Goodkin DA; Bailie GR
    Kidney Int; 2015 Jun; 87(6):1261-2. PubMed ID: 26024036
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.
    Brookhart MA; Freburger JK; Ellis AR; Wang L; Winkelmayer WC; Kshirsagar AV
    J Am Soc Nephrol; 2013 Jun; 24(7):1151-8. PubMed ID: 23787911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous iron in hemodialysis patients.
    Li X; Kshirsagar AV; Brookhart MA
    Hemodial Int; 2017 Jun; 21 Suppl 1(Suppl 1):S93-S103. PubMed ID: 28370957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients.
    Kshirsagar AV; Freburger JK; Ellis AR; Wang L; Winkelmayer WC; Brookhart MA
    PLoS One; 2013; 8(11):e78930. PubMed ID: 24223866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis.
    Sato M; Hanafusa N; Tsuchiya K; Kawaguchi H; Nitta K
    Blood Purif; 2019; 48(2):158-166. PubMed ID: 31311016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis: Long weekend hemodialysis intervals--killing fields?
    Vanholder R; Veys N; Van Biesen W
    Nat Rev Nephrol; 2011 Nov; 8(1):5-6. PubMed ID: 22105158
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous iron administration: new observations and time for the next steps.
    Weiss G; Kronenberg F
    Kidney Int; 2015 Jan; 87(1):10-2. PubMed ID: 25549119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is vitamin D receptor gene polymorphism an independent predictor of mortality in hemodialysis patients?
    Ertürk S; Kutlay S; Keven K
    Am J Kidney Dis; 2002 Feb; 39(2):441-2. PubMed ID: 11840393
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis.
    Hougen I; Collister D; Bourrier M; Ferguson T; Hochheim L; Komenda P; Rigatto C; Tangri N
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):457-467. PubMed ID: 29463597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.
    Bailie GR; Larkina M; Goodkin DA; Li Y; Pisoni RL; Bieber B; Mason N; Tong L; Locatelli F; Marshall MR; Inaba M; Robinson BM
    Kidney Int; 2015 Jan; 87(1):162-8. PubMed ID: 25075769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study.
    Arase H; Yamada S; Hiyamuta H; Taniguchi M; Tokumoto M; Tsuruya K; Nakano T; Kitazono T
    Sci Rep; 2020 Jan; 10(1):1241. PubMed ID: 31988325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risks for hemodialysis and peritoneal dialysis patients.
    Alpert MA
    Nephrol News Issues; 1995 May; 9(5):12-8. PubMed ID: 7777065
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
    Winkelmayer WC; Goldstein BA; Mitani AA; Ding VY; Airy M; Mandayam S; Chang TI; Brookhart MA; Fishbane S
    Am J Kidney Dis; 2017 Jun; 69(6):771-779. PubMed ID: 28063734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic hemodialysis.
    Mc Causland FR; Brunelli SM; Waikar SS
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1827-35. PubMed ID: 22917700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: a nationwide cohort-based case-crossover study.
    Yen CL; Lin YS; Lu YA; Lee HF; Lee CC; Tung YC; Kuo G; Wu LS; Tian YC; Chu PH
    BMC Nephrol; 2019 Aug; 20(1):327. PubMed ID: 31438879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with high-dose intravenous iron increases mortality and hospitalization in hemodialysis. The basic idea is more important than the style].
    Fernández-Gallego J
    Nefrologia; 2005; 25(3):340. PubMed ID: 16053019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.